Entrada Property Plant Equipment vs Total Current Assets Analysis

TRDA Stock

USD 13.44 0.81 6.41%

Entrada Therapeutics financial indicator trend analysis is much more than just examining Entrada Therapeutics latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Entrada Therapeutics is a good investment. Please check the relationship between Entrada Therapeutics Property Plant Equipment and its Total Current Assets accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Entrada Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For information on how to trade Entrada Stock refer to our How to Trade Entrada Stock guide.

Property Plant Equipment vs Total Current Assets

Property Plant Equipment vs Total Current Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Entrada Therapeutics Property Plant Equipment account and Total Current Assets. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Entrada Therapeutics' Property Plant Equipment and Total Current Assets is 0.91. Overlapping area represents the amount of variation of Property Plant Equipment that can explain the historical movement of Total Current Assets in the same time period over historical financial statements of Entrada Therapeutics, assuming nothing else is changed. The correlation between historical values of Entrada Therapeutics' Property Plant Equipment and Total Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Property Plant Equipment of Entrada Therapeutics are associated (or correlated) with its Total Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Assets has no effect on the direction of Property Plant Equipment i.e., Entrada Therapeutics' Property Plant Equipment and Total Current Assets go up and down completely randomly.

Correlation Coefficient

0.91

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Property Plant Equipment

Total Current Assets

The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.

Most indicators from Entrada Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Entrada Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Entrada Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For information on how to trade Entrada Stock refer to our How to Trade Entrada Stock guide.The current year's Tax Provision is expected to grow to about 22.6 M, whereas Selling General Administrative is forecasted to decline to about 19.2 M.

	2023	2024	2025 (projected)
Depreciation And Amortization	2.8M	3.3M	3.4M
Interest Income	15.2M	17.5M	18.4M

Depreciation And Amortization Interest Income

Entrada Therapeutics fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Non Current Liabilities Other	Net Working Capital	Common Stock	Property Plant Equipment
Total Assets		0.92	0.93	0.88	0.76	0.84	0.95	-0.1	-0.93	0.68	0.55	0.95	0.96	0.97	0.81	0.35	0.79	0.85	0.87	0.88	0.95	1.0	-0.73	0.88	0.91	0.93
Other Current Liab	0.92		0.95	0.71	0.59	0.65	0.92	-0.03	-0.73	0.4	0.47	0.91	0.84	0.97	0.86	0.49	0.5	0.69	0.93	0.71	0.92	0.91	-0.77	0.71	0.72	0.78
Total Current Liabilities	0.93	0.95		0.67	0.58	0.61	0.99	0.22	-0.81	0.58	0.26	0.99	0.93	0.91	0.89	0.56	0.61	0.61	0.98	0.67	0.99	0.9	-0.79	0.65	0.72	0.89
Total Stockholder Equity	0.88	0.71	0.67		0.83	1.0	0.72	-0.41	-0.89	0.68	0.74	0.73	0.8	0.84	0.6	0.07	0.86	0.98	0.56	1.0	0.72	0.91	-0.39	0.99	0.99	0.79
Other Liab	0.76	0.59	0.58	0.83		0.82	0.63	-0.32	-0.84	0.73	0.6	0.64	0.76	0.7	0.53	0.42	0.79	0.87	0.57	0.83	0.63	0.78	-0.3	0.87	0.86	0.73
Net Tangible Assets	0.84	0.65	0.61	1.0	0.82		0.66	-0.47	-0.86	0.67	0.76	0.67	0.76	0.8	0.54	0.01	0.86	0.98	0.5	1.0	0.66	0.88	-0.34	0.99	0.98	0.76
Property Plant And Equipment Net	0.95	0.92	0.99	0.72	0.63	0.66		0.21	-0.87	0.67	0.27	1.0	0.96	0.9	0.88	0.53	0.7	0.65	0.97	0.72	1.0	0.92	-0.78	0.69	0.77	0.94
Net Debt	-0.1	-0.03	0.22	-0.41	-0.32	-0.47	0.21		0.03	0.19	-0.88	0.21	0.13	-0.2	0.21	0.49	-0.07	-0.54	0.3	-0.41	0.22	-0.18	-0.17	-0.48	-0.3	0.16
Retained Earnings	-0.93	-0.73	-0.81	-0.89	-0.84	-0.86	-0.87	0.03		-0.89	-0.44	-0.89	-0.96	-0.81	-0.66	-0.32	-0.94	-0.84	-0.76	-0.89	-0.88	-0.92	0.53	-0.87	-0.94	-0.97
Accounts Payable	0.68	0.4	0.58	0.68	0.73	0.67	0.67	0.19	-0.89		0.12	0.7	0.83	0.48	0.51	0.29	0.95	0.62	0.55	0.68	0.68	0.66	-0.35	0.65	0.77	0.87
Cash	0.55	0.47	0.26	0.74	0.6	0.76	0.27	-0.88	-0.44	0.12		0.27	0.33	0.63	0.21	-0.25	0.39	0.83	0.16	0.74	0.27	0.62	-0.23	0.8	0.65	0.3
Non Current Assets Total	0.95	0.91	0.99	0.73	0.64	0.67	1.0	0.21	-0.89	0.7	0.27		0.97	0.9	0.87	0.52	0.72	0.66	0.96	0.73	1.0	0.92	-0.78	0.7	0.79	0.95
Non Currrent Assets Other	0.96	0.84	0.93	0.8	0.76	0.76	0.96	0.13	-0.96	0.83	0.33	0.97		0.86	0.8	0.45	0.85	0.75	0.89	0.8	0.97	0.94	-0.71	0.78	0.86	0.99
Cash And Short Term Investments	0.97	0.97	0.91	0.84	0.7	0.8	0.9	-0.2	-0.81	0.48	0.63	0.9	0.86		0.81	0.36	0.62	0.83	0.86	0.84	0.9	0.97	-0.72	0.85	0.84	0.82
Common Stock Shares Outstanding	0.81	0.86	0.89	0.6	0.53	0.54	0.88	0.21	-0.66	0.51	0.21	0.87	0.8	0.81		0.59	0.53	0.54	0.88	0.6	0.87	0.78	-0.76	0.58	0.66	0.77
Non Current Liabilities Total	0.35	0.49	0.56	0.07	0.42	0.01	0.53	0.49	-0.32	0.29	-0.25	0.52	0.45	0.36	0.59		0.12	0.06	0.69	0.07	0.53	0.3	-0.3	0.09	0.17	0.39
Other Current Assets	0.79	0.5	0.61	0.86	0.79	0.86	0.7	-0.07	-0.94	0.95	0.39	0.72	0.85	0.62	0.53	0.12		0.81	0.53	0.86	0.7	0.79	-0.36	0.83	0.91	0.89
Other Stockholder Equity	0.85	0.69	0.61	0.98	0.87	0.98	0.65	-0.54	-0.84	0.62	0.83	0.66	0.75	0.83	0.54	0.06	0.81		0.52	0.98	0.65	0.89	-0.39	1.0	0.96	0.73
Total Liab	0.87	0.93	0.98	0.56	0.57	0.5	0.97	0.3	-0.76	0.55	0.16	0.96	0.89	0.86	0.88	0.69	0.53	0.52		0.56	0.97	0.83	-0.79	0.55	0.63	0.85
Net Invested Capital	0.88	0.71	0.67	1.0	0.83	1.0	0.72	-0.41	-0.89	0.68	0.74	0.73	0.8	0.84	0.6	0.07	0.86	0.98	0.56		0.72	0.91	-0.39	0.99	0.99	0.79
Property Plant And Equipment Gross	0.95	0.92	0.99	0.72	0.63	0.66	1.0	0.22	-0.88	0.68	0.27	1.0	0.97	0.9	0.87	0.53	0.7	0.65	0.97	0.72		0.92	-0.78	0.69	0.78	0.94
Total Current Assets	1.0	0.91	0.9	0.91	0.78	0.88	0.92	-0.18	-0.92	0.66	0.62	0.92	0.94	0.97	0.78	0.3	0.79	0.89	0.83	0.91	0.92		-0.7	0.91	0.93	0.91
Non Current Liabilities Other	-0.73	-0.77	-0.79	-0.39	-0.3	-0.34	-0.78	-0.17	0.53	-0.35	-0.23	-0.78	-0.71	-0.72	-0.76	-0.3	-0.36	-0.39	-0.79	-0.39	-0.78	-0.7		-0.4	-0.44	-0.69
Net Working Capital	0.88	0.71	0.65	0.99	0.87	0.99	0.69	-0.48	-0.87	0.65	0.8	0.7	0.78	0.85	0.58	0.09	0.83	1.0	0.55	0.99	0.69	0.91	-0.4		0.98	0.77
Common Stock	0.91	0.72	0.72	0.99	0.86	0.98	0.77	-0.3	-0.94	0.77	0.65	0.79	0.86	0.84	0.66	0.17	0.91	0.96	0.63	0.99	0.78	0.93	-0.44	0.98		0.86
Property Plant Equipment	0.93	0.78	0.89	0.79	0.73	0.76	0.94	0.16	-0.97	0.87	0.3	0.95	0.99	0.82	0.77	0.39	0.89	0.73	0.85	0.79	0.94	0.91	-0.69	0.77	0.86

Click cells to compare fundamentals

Entrada Therapeutics Account Relationship Matchups

Entrada Therapeutics fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	43.5M	305.8M	252.1M	469.2M	539.6M	566.5M
Other Current Liab	1.8M	6.0M	(830K)	11.3M	13.0M	13.7M
Total Current Liabilities	3.4M	6.7M	22.0M	158.8M	182.6M	191.7M
Total Stockholder Equity	(41.5M)	298.7M	212.6M	242.4M	278.7M	153.3M
Property Plant And Equipment Net	3.0M	6.3M	33.0M	92.7M	106.6M	111.9M
Net Debt	(39.0M)	(291.1M)	(19.2M)	628K	722.2K	758.3K
Retained Earnings	(42.5M)	(93.7M)	(188.3M)	(195.0M)	(175.5M)	(166.7M)
Accounts Payable	1.6M	706K	6.0M	3.3M	3.8M	2.7M
Cash	39.0M	291.1M	45.2M	67.6M	77.7M	101.1M
Non Current Assets Total	3.6M	7.1M	42.2M	99.4M	114.3M	120.1M
Non Currrent Assets Other	541K	872K	5.2M	6.7M	7.8M	8.1M
Cash And Short Term Investments	39.0M	291.1M	45.2M	352.0M	404.8M	425.0M
Liabilities And Stockholders Equity	43.5M	305.8M	252.1M	469.2M	539.6M	566.5M
Non Current Liabilities Total	81.7M	396K	17.5M	68.0M	78.2M	43.9M
Other Current Assets	904K	7.6M	21.2M	11.9M	13.7M	9.3M
Other Stockholder Equity	82.7M	698.2M	402.9M	437.1M	502.7M	356.7M
Total Liab	85.0M	7.1M	39.5M	226.8M	260.9M	273.9M
Net Invested Capital	(41.5M)	298.7M	212.6M	242.4M	278.7M	153.3M
Property Plant And Equipment Gross	3.4M	6.3M	36.3M	98.6M	113.4M	119.1M
Total Current Assets	39.9M	298.7M	209.9M	369.8M	425.2M	446.5M
Accumulated Other Comprehensive Income	(81.7M)	(305.8M)	(2.1M)	195K	224.3K	235.5K
Net Working Capital	36.6M	292.0M	187.9M	211.0M	242.6M	163.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CSX	CSX Corporation
ETON	Eton Pharmaceuticals
ALLT	Allot Communications

When determining whether Entrada Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Entrada Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Entrada Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Entrada Therapeutics Stock:

How To Invest In Entrada

Details

Is Entrada Stock a good investment?

Details

What is Entrada Therapeutics' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Entrada Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For information on how to trade Entrada Stock refer to our How to Trade Entrada Stock guide.

You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Entrada Therapeutics. If investors know Entrada will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Entrada Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

1.44

Revenue Per Share

6.074

Quarterly Revenue Growth

(0.55)

Return On Assets

0.0695

Return On Equity

0.1642

The market value of Entrada Therapeutics is measured differently than its book value, which is the value of Entrada that is recorded on the company's balance sheet. Investors also form their own opinion of Entrada Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Entrada Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Entrada Therapeutics' market value can be influenced by many factors that don't directly affect Entrada Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Entrada Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Entrada Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Entrada Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Entrada Property Plant Equipment vs Total Current Assets Analysis

Property Plant Equipment vs Total Current Assets

Property Plant Equipment vs Total Current Assets Correlation Analysis

Correlation Coefficient

Property Plant Equipment

Total Current Assets

Entrada Therapeutics fundamental ratios Correlations

Entrada Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Entrada Therapeutics fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Net Tangible Assets	+ 1.0	Total Stockholder Equity
Net Invested Capital	+ 1.0	Total Stockholder Equity
Net Invested Capital	+ 1.0	Net Tangible Assets
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net

Property Plant Equipment	- 0.97	Retained Earnings
Non Currrent Assets Other	- 0.96	Retained Earnings
Common Stock	- 0.94	Retained Earnings
Other Current Assets	- 0.94	Retained Earnings
Retained Earnings	- 0.93	Total Assets
Total Current Assets	- 0.92	Retained Earnings